DUPIXENT is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP).
Some examples of CRSwNP patients who may be appropriate for DUPIXENT are:
NSAID-ERD, nonsteroidal anti-inflammatory drug–exacerbated respiratory disease.
Explore patient types appropriate for DUPIXENT